IRIS - Res&Arch Institutional Research Information System - Research & Archive

GAETANI, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.447
EU - Europa 1.038
AS - Asia 764
SA - Sud America 160
AF - Africa 16
OC - Oceania 5
Totale 3.430
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.430
SG - Singapore 322
IT - Italia 273
HK - Hong Kong 260
IE - Irlanda 220
BR - Brasile 141
RU - Federazione Russa 123
DE - Germania 107
CN - Cina 102
FI - Finlandia 69
SE - Svezia 63
NL - Olanda 26
UA - Ucraina 22
GB - Regno Unito 20
RO - Romania 19
BE - Belgio 18
CZ - Repubblica Ceca 17
AT - Austria 14
FR - Francia 14
IN - India 10
JP - Giappone 9
KR - Corea 9
GR - Grecia 8
HR - Croazia 8
UZ - Uzbekistan 8
VN - Vietnam 8
TR - Turchia 7
BD - Bangladesh 6
AR - Argentina 5
CA - Canada 5
MA - Marocco 5
NZ - Nuova Zelanda 5
CO - Colombia 4
EC - Ecuador 4
EG - Egitto 4
IQ - Iraq 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
JM - Giamaica 3
PL - Polonia 3
PT - Portogallo 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
CH - Svizzera 2
DK - Danimarca 2
ES - Italia 2
IR - Iran 2
KZ - Kazakistan 2
NI - Nicaragua 2
PK - Pakistan 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
VE - Venezuela 2
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
GY - Guiana 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
NP - Nepal 1
PA - Panama 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.430
Salva come PNG Salva come JPEG
Città #
Chandler 257
Hong Kong 251
Singapore 239
Dublin 220
Perugia 140
Boardman 123
Santa Clara 77
San Mateo 68
Munich 67
Altamura 59
Moscow 56
Ashburn 43
Des Moines 42
Medford 40
Princeton 40
Andover 39
Lawrence 39
Ann Arbor 38
Los Angeles 36
Wilmington 35
Helsinki 30
Beijing 27
Turku 26
Redmond 24
Redwood City 18
The Dalles 16
Amsterdam 14
Brussels 14
Falls Church 13
Nuremberg 13
Brno 12
Rome 12
São Paulo 11
Vienna 11
Timisoara 10
Houston 9
Seoul 9
Columbus 8
Seattle 8
Tokyo 8
Zagreb 8
Chicago 7
Dallas 7
Fairfield 7
Milan 7
Bucharest 6
Falkenstein 6
Lappeenranta 6
Norwalk 6
Saint Petersburg 6
San Francisco 6
Tashkent 6
Auckland 5
Boston 5
Brooklyn 5
Campinas 5
Dong Ket 5
Secaucus 5
Woodbridge 5
New York 4
Phoenix 4
Porto Alegre 4
Athens 3
Belo Horizonte 3
Frankfurt am Main 3
Giza 3
Groningen 3
Guangzhou 3
Izmir 3
London 3
Newark 3
Olomouc 3
Rabat 3
Rio de Janeiro 3
Salvador 3
Shenzhen 3
Stockholm 3
Wielsbeke 3
Adrogué 2
Atlanta 2
Belém 2
Bogotá 2
Brixen 2
Cambridge 2
Canzo 2
Charlotte 2
Chennai 2
Curitiba 2
Deruta 2
Dhaka 2
Dubai 2
Foligno 2
Jacksonville 2
Jeddah 2
Joinville 2
Kingston 2
Kolkata 2
Maceió 2
Managua 2
Manchester 2
Totale 2.419
Salva come PNG Salva come JPEG
Nome #
CSF and blood biomarkers for Parkinson's disease 146
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 107
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 107
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 100
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 95
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 84
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 81
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 73
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 73
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 72
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 72
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 67
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 65
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 65
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis 62
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature 62
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction 57
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 56
Molecular profiling in Parkinsonian syndromes: CSF biomarkers 55
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 55
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica 53
Serum neurofilament light chain as a preclinical marker of neurodegeneration 52
Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: Implications for early and differential diagnosis 52
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 51
Synaptic dysfunction in multiple sclerosis: A red thread from inflammation to network disconnection 51
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 50
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease 49
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers. 49
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain 49
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 48
Author Response: NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use 47
Infliximab monotherapy for neuro-Behçet's disease: a case report 47
Neurofilament light chain as a biomarker in neurological disorders 46
Finding a way to preserve mitochondria: New pathogenic pathways in experimental multiple sclerosis 46
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease 46
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis. 45
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 45
Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms 45
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 45
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 44
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 44
The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI 44
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion 43
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 42
A blood test for Alzheimer's disease: a step forward 41
Blood biomarkers may distinguish among dementia disorders 40
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 36
Impact of post-contrast MRI in the definition of active multiple sclerosis 36
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 36
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 34
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 33
Clinical correlates of state and trait anxiety in multiple sclerosis 32
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 31
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 31
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 31
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 30
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents 29
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 28
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 28
Biomarker-Based Prediction of Parkinson Disease: Time for a Shift in Neurologists' Attitude Toward Neurodegenerative Diseases 27
Does cerebrospinal fluid neurofilament light chain correlate with psychiatric symptoms severity in multiple sclerosis? 27
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 26
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 25
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 25
CSF synaptic biomarkers and cognitive impairment in multiple sclerosis 25
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 23
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 23
SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis 20
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 20
Intrathecal B cell activation and memory impairment in multiple sclerosis 19
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 18
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease 18
Research advancement in fluid biomarkers for Parkinson's disease 18
Fluid biomarkers in multiple sclerosis: from current to future applications 17
Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study 16
Hippocampal neuroplasticity and inflammation: Relevance for multiple sclerosis 16
Cerebrospinal fluid interferon-γ and development of depression in multiple sclerosis 13
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 7
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective 4
Totale 3.570
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.727
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 3 4 4 1 74 17 7 20 11 5 6 7
2021/2022380 3 49 12 12 26 10 5 93 17 46 61 46
2022/2023858 45 184 15 68 62 104 4 38 302 1 26 9
2023/2024511 24 54 15 11 7 2 97 20 68 26 80 107
2024/20251.392 13 108 69 75 122 103 95 139 239 85 220 124
2025/202683 83 0 0 0 0 0 0 0 0 0 0 0
Totale 3.570